[
  {
    "ts": null,
    "headline": "Gilead Sciences Inc. stock underperforms Wednesday when compared to competitors",
    "summary": "Gilead Sciences Inc. stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=e90658b1d25603a50979d92b016f0900e504ffe77c29310fb0fd52ca8dcfe928",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754498160,
      "headline": "Gilead Sciences Inc. stock underperforms Wednesday when compared to competitors",
      "id": 136252173,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Sciences Inc. stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=e90658b1d25603a50979d92b016f0900e504ffe77c29310fb0fd52ca8dcfe928"
    }
  },
  {
    "ts": null,
    "headline": "Compugen Reports Second Quarter 2025 Results",
    "summary": "Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery powered by AI/ML, today reported financial results for the second quarter of 2025 and provided a corporate update.",
    "url": "https://finnhub.io/api/news?id=47bc9392fb29ac5ac25b84fa2fdc10590c0f6b582640e9c29d1d6f504176a763",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754478000,
      "headline": "Compugen Reports Second Quarter 2025 Results",
      "id": 136232384,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery powered by AI/ML, today reported financial results for the second quarter of 2025 and provided a corporate update.",
      "url": "https://finnhub.io/api/news?id=47bc9392fb29ac5ac25b84fa2fdc10590c0f6b582640e9c29d1d6f504176a763"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences (GILD) Reports Q2: Everything You Need To Know Ahead Of Earnings",
    "summary": "Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be reporting results this Thursday after market close. Here’s what investors should know.",
    "url": "https://finnhub.io/api/news?id=de0c9ca46cf8ce7f3394015a81abfdc01e6a9c46dc2dddae0255035525d6e249",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754449922,
      "headline": "Gilead Sciences (GILD) Reports Q2: Everything You Need To Know Ahead Of Earnings",
      "id": 136232385,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be reporting results this Thursday after market close. Here’s what investors should know.",
      "url": "https://finnhub.io/api/news?id=de0c9ca46cf8ce7f3394015a81abfdc01e6a9c46dc2dddae0255035525d6e249"
    }
  }
]